Search results
Targeting glutamine metabolism improves sarcoma response to radiation therapy in vivo -...
Nature· 4 days agoUsing primary mouse model of soft-tissue sarcoma (STS), authors show that sarcoma switches to glutamine metabolism post radiation therapy, and inhibition ...
EpicentRx Announces Oral Presentation for the Most Clinically Advanced TGF-β Ligand Trap, AdAPT-001,...
WROC Rochester· 11 hours agoAnthony P. Conley, an MD Anderson Cancer Center (MDACC) Sarcoma Specialist and Lead PI, to give an oral presentation on the unprecedented clinical activity of AdAPT-001 plus ...
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug...
WPRI Providence· 7 hours agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its ...
Reproductive cancer survivor beats disease, but is left with medical debt crisis
The Star Press via Yahoo News· 23 hours ago“My abdomen felt dull and sharp at the same time. I knew something was really wrong,” she said....
Vinmec Central Park Hospital joins Cleveland Clinic Connected programme
Hospital Management via Yahoo Finance· 19 hours agoAs part of the Cleveland Clinic Connected network, Vinmec's cardiology and sarcoma centres have...
Volleyball player takes on his toughest opponent: | Newswise
Newswise· 1 day agoIt was cancer — an extremely rare, aggressive cancer called desmoplastic small round cell tumors, the cancer is a soft tissue sarcoma that produces tumors in the abdomen and ...
Anti-inflammatory diet guide: Foods, benefits and meal plan
The Telegraph via Yahoo News· 4 days agoIgnore chronic inflammation at your peril. Recognised as a contributor to many deaths globally, half...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 11 hours agoZentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental ...
'I was looking at my child, planning his funeral': The horror of the infected blood scandal, by the...
Daily Telegraph· 5 days agoThe infected blood scandal can only be described as a catalogue of heartbreak. More than 30,000...
Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 as Monotherapy or Combined with...
Morningstar· 4 days agoPRINCETON, NJ / ACCESSWIRE / May 20, 2024 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing targeted immunotherapeutic drugs ...